Literature DB >> 21468678

Temporal lobe epilepsy and anti glutamic acid decarboxylase autoimmunity.

Luca Errichiello1, Salvatore Striano, Federico Zara, Pasquale Striano.   

Abstract

Epilepsy is one of the most impactful diseases on social life. A significant number of epileptic syndromes have been linked to immunological alterations. Elevated levels of antibodies against glutamic acid decarboxylase have been recently found in a significant percentage of patients with temporal lobe epilepsy, the most common epilepsy type. The clinical and pathogenetic relationship of this association is discussed. This link may have important therapeutic implications and merits additional clinical and laboratory research.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21468678     DOI： 10.1007/s10072-011-0566-8

Source DB:  PubMed          Journal:  Neurol Sci        ISSN： 1590-1874            Impact factor:   3.307


  39 in total

1.  Cleft palate and decreased brain gamma-aminobutyric acid in mice lacking the 67-kDa isoform of glutamic acid decarboxylase.

Authors:  H Asada; Y Kawamura; K Maruyama; H Kume; R G Ding; N Kanbara; H Kuzume; M Sanbo; T Yagi; K Obata
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

2.  Antigenic differences between neurological and diabetic patients with anti-glutamic acid decarboxylase antibodies.

Authors:  M Vianello; G Keir; B Giometto; C Betterle; B Tavolato; E J Thompson
Journal:  Eur J Neurol       Date:  2005-04       Impact factor: 6.089

Review 3.  GABAergic mechanisms in epilepsy.

Authors:  D M Treiman
Journal:  Epilepsia       Date:  2001       Impact factor: 5.864

Review 4.  Clinical trials of antiepileptic medications in newly diagnosed patients with epilepsy.

Authors:  Patrick Kwan; Martin J Brodie
Journal:  Neurology       Date:  2003-06-10       Impact factor: 9.910

Review 5.  Age-dependent vulnerability to seizures.

Authors:  E F Sperber; J Velísková; I M Germano; L K Friedman; S L Moshé
Journal:  Adv Neurol       Date:  1999

6.  Internalization of IgG in motoneurons of patients with ALS: selective or nonselective?

Authors:  P S Fishman; D B Drachman
Journal:  Neurology       Date:  1995-08       Impact factor: 9.910

7.  Cerebrospinal fluid amino acid and monoamine metabolite levels of Papio papio: correlation with photosensitivity.

Authors:  K G Lloyd; B Scatton; C Voltz; P Bryere; A Valin; R Naquet
Journal:  Brain Res       Date:  1986-01-22       Impact factor: 3.252

8.  Clinical significance of glutamic acid decarboxylase antibodies in patients with epilepsy.

Authors:  Suvi Liimatainen; Maria Peltola; Lidia Sabater; Mahdi Fallah; Elham Kharazmi; Anna-Maija Haapala; Prasun Dastidar; Mikael Knip; Albert Saiz; Jukka Peltola
Journal:  Epilepsia       Date:  2009-10-08       Impact factor: 5.864

9.  Demonstration of functional coupling between gamma -aminobutyric acid (GABA) synthesis and vesicular GABA transport into synaptic vesicles.

Authors:  Hong Jin; Heng Wu; Gregory Osterhaus; Jianning Wei; Kathleen Davis; Di Sha; Eric Floor; Che-Chang Hsu; Richard D Kopke; Jang-Yen Wu
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-12       Impact factor: 11.205

10.  Pathological alterations in GABAergic interneurons and reduced tonic inhibition in the basolateral amygdala during epileptogenesis.

Authors:  B Fritsch; F Qashu; T H Figueiredo; V Aroniadou-Anderjaska; M A Rogawski; M F M Braga
Journal:  Neuroscience       Date:  2009-06-18       Impact factor: 3.590
View more
  8 in total

Review 1.  Antibodies in epilepsy.

Authors:  Cynthia M Correll
Journal:  Curr Neurol Neurosci Rep       Date:  2013-05       Impact factor: 5.081

2.  The Concise Guide to PHARMACOLOGY 2013/14: enzymes.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

3.  Stiff-person syndrome: case series.

Authors:  Yu Jin Jung; Han G Jeong; Ryul Kim; Han-Joon Kim; Beom S Jeon
Journal:  J Mov Disord       Date:  2014-04-30

Review 4.  Pathophysiogenesis of mesial temporal lobe epilepsy: is prevention of damage antiepileptogenic?

Authors:  G Curia; C Lucchi; J Vinet; F Gualtieri; C Marinelli; A Torsello; L Costantino; G Biagini
Journal:  Curr Med Chem       Date:  2014       Impact factor: 4.530

5.  Inhibition of glutamate decarboxylase (GAD) by ethyl ketopentenoate (EKP) induces treatment-resistant epileptic seizures in zebrafish.

Authors:  Yifan Zhang; Michiel Vanmeert; Aleksandra Siekierska; Annelii Ny; Jubi John; Geert Callewaert; Eveline Lescrinier; Wim Dehaen; Peter A M de Witte; Rafal M Kaminski
Journal:  Sci Rep       Date:  2017-08-03       Impact factor: 4.379

Review 6.  Diagnostic Value of Structural and Functional Neuroimaging in Autoimmune Epilepsy.

Authors:  Limei Luo; Nian Wei; Jing Wang; Yuemei Luo; Fei Yang; Zucai Xu
Journal:  Contrast Media Mol Imaging       Date:  2020-12-14       Impact factor: 3.161

7.  Modulation of Immunity and the Inflammatory Response: A New Target for Treating Drug-resistant Epilepsy.

Authors:  Nian Yu; Hao Liu; Qing Di
Journal:  Curr Neuropharmacol       Date:  2013-01       Impact factor: 7.363

8.  GAD65 autoantibody characteristics in patients with co-occurring type 1 diabetes and epilepsy may help identify underlying epilepsy etiologies.

Authors:  Suvi Liimatainen; Jerome Honnorat; Sean J Pittock; Andrew McKeon; Mario Manto; Jared R Radtke; Christiane S Hampe
Journal:  Orphanet J Rare Dis       Date:  2018-04-10       Impact factor: 4.123
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.